Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lentiviral vector therapeutic HBV vaccine
- Development stage
- Preclinical
- Lead developer
- Shanghai Jinwei Biotechnology
- Modality
- Gene Therapies, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Lentiviral Vector Therapeutic HBV Vaccine is a preclinical-stage gene therapy and vaccine candidate developed by Jinwei Biotechnology for the treatment of chronic hepatitis B. The vaccine utilizes a lentiviral vector platform to deliver Hepatitis B virus (HBV) antigens directly to antigen-presenting cells (APCs), such as dendritic cells and macrophages. By transducing these cells, the vaccine is designed to overcome the immune tolerance typically observed in chronic HBV infection and stimulate robust, multi-epitope HBV-specific T-cell responses. This immunotherapeutic approach aims to promote the clearance of HBV-infected hepatocytes and achieve a functional cure for chronic hepatitis B.
- Other names
- Lentiviral Vector Therapeutic HBV Vaccine
02
Targets
HBV-specific TCR (Hepatitis B virus PreS2/core-specific T-cell receptor)
Beyond the preview
Go deeper on lentiviral vector therapeutic HBV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lentiviral vector therapeutic HBV vaccine.